Nigeria needs at least $1.6bn over the next ten years to support the purchase of vaccines and immunization activities if it hopes to drastically reduce child-killer diseases. This was made known to senators by a delegation from the National Primary Healthcare Development Agency, Global Alliance for Vaccines and Immunization (GAVI), World Health Organisation and other international donors.
According to a study which found that infants living with single mothers who have similar facial features to their fathers tend to be healthier after one year, dad’s looks are best. For a baby’s health, that is. That’s because a youngster who closely resembles his or her dad is more likely to spend time with him, a factor that can improve a child’s well-being.
UNAIDS is ecstatic with mid-way results from two studies that show a vaginal ring releasing long-acting antiretroviral medicine to prevent HIV infection in women.
According to reports, the results show that the process is up to 54 percent effective in preventing HIV.
The Jigawa Government Commissioner for Health, Dr Abba Zakari, says meningitis has killed 14 persons as 51 suspected cases were recorded in 10 local government areas of the state. Zakari who disclosed this to Newsmen in Dutse on Wednesday said that 51 suspected cases of Cerebro Spinal Meningitis (CSM) had so far been reported to the ministry since November 2017.
The World Health Organisation (WHO) on Monday, revealed that it plans to spend up to $178 million between 2018 and 2019, on solving health related problems in Nigeria.
The WHO Country Representative, Wondimagegnehu Alemu, revealed this at the joint approval of the Biennium WHO Programme Budget of 2018 to 2019, in Abuja, with the Minister of Health, Isaac Adewole in attendance.
According to Mr. Alemu $127 million, representing 66 per cent of the budget, would be channeled towards polio eradication programmes.
Medical experts revealed the discovery of a Human Immunodeficiency Virus (HIV) antibody that can suppress the virus for up to six months without additional treatment.
The study result, which was released at the 25th Conference on Retroviruses and Opportunistic Infections in Boston, lend a clue to approaches that try to achieve sustained, drug-free viral remission in people living with HIV.
Being partly supported by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), the research may have targeted the viral reservoir, populations of long-lived, latently infected cells that harbour the virus and that lead to resurgent viral reproduction when suppressive therapy was stopped.
